Multidisciplinary therapy and immune checkpoint inhibitors achieve complete remission in a NUT midline carcinoma case
Multidisciplinary treatment leads to remission in rare nasal cavity cancer
This case report and literature review describes a single patient with NUT midline carcinoma of the nasal cavity who achieved complete remis…
A patient with a rare and aggressive nasal cavity cancer achieved complete remission through a combination of chemotherapy, surgery, and rad…
Chemoimmunotherapy improves survival in solid tumors regardless of liver metastasis status
Chemoimmunotherapy helps solid tumor patients, with or without liver metastases
This systematic review and meta-analysis evaluated 25915 patients with solid tumors receiving chemoimmunotherapy versus chemotherapy alone. …
For people with solid tumors, adding immunotherapy to chemo helps survival whether or not cancer has spread to the liver.
Early time-of-day immune checkpoint inhibitor administration improves overall survival in advanced solid tumors
Cancer Patients Live Longer When Immunotherapy Starts Early in Day
This systematic review and meta-analysis evaluated 6129 patients with advanced solid tumors receiving immune checkpoint inhibitors. Earlier …
• Morning immunotherapy shots link to longer survival for advanced cancers • Helps patients fighting lung stomach kidney and other tough can…